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ABSTRACT
Background: When patients need a surgical procedure, the natural reaction is to have a
heightened sense of anxiety. This anxiety can be regarded as an unwanted response, as it can
affect the patient’s perception of the procedure and how pain is experienced. In children, the fear
of the unknown and the new can be a traumatizing event in their lives; therefore, it should be
considered how practitioners help handle this anxiety and apprehension. Medications such as
midazolam and dexmedetomidine are used to help modify this emotion.
Aim: This systematic review aims to investigate the potential benefits of using dexmedetomidine
intranasally instead of midazolam to help cope with this preoperative sedation and postoperative
emergence in the pediatric population. An education module was also deployed to help improve
the current knowledge of certified nurse anesthetists working within the pediatric population.
Results: All 10 studies were randomized controlled trials (RCT) with a minimum level 1C
appraisal designation according to the Johns Hopkins research evidence appraisal tool. 11 A total
of 828 children were selected for these trials in all parts of the world. The ages ranged from 2-14
years old. Four of the RCTs used comparable levels of sedation compared to the 10 studies when
comparing dexmedetomidine and midazolam. Six of the remaining RCTs had better results
regarding sedation levels and were recommended by the authors. The statistical analysis between
the pre-test and post-test of the education module showed an increase in provider knowledge.
Discussion: The results from 10 RCTs demonstrate that dexmedetomidine is indeed a better
preoperative medication for sedation and has the added benefit of analgesic properties to help
postoperatively. The drawback is the cost difference when compared to midazolam. The other
potential downside is the onset of action time is slower with dexmedetomidine versus midazolam
in reaching optimal sedation levels.
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Conclusion: The studies' results have been consistent and clear that dexmedetomidine is superior
to midazolam for preoperative sedation and postoperative analgesia. The use of dexmedetomidine
can help curb unwanted side effects as well such as respiratory depression with midazolam. The
movement to change this common practice of midazolam should be done with the sole focus of
improving patient experiences and outcomes.
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INTRODUCTION
Problem Identification
In the world of children, fear of the unknown and the unfamiliar poses a problem as
practitioners across the country struggle to prepare these pediatric patients for any procedure
properly. This fear or anxiety can cause hemodynamic instability, metabolic side effects,
increased postoperative pain, and emergence agitation.1 Various studies have shown that this
preoperative anxiety continues after the procedure, as the children require more pain medication
and have difficulty with sleep.2 A vast majority of children undergoing surgery experience mental
anguish and stress during the entire period. Several research studies have evaluated the role
different factors play in negative behavior manifestation and postoperative anxiety, including
parents and children's preoperative anxiety, the history of surgery, preoperative preparation and
medication, the anesthetic used, the child's experience in the postoperative care unit, and length of
hospitalization.2
In addition to the inherent problems when dealing with children, such as separation
anxiety and managing parents' expectations, it also comes with choosing medications that can
produce the best outcomes. The current situation leaves practitioners limited regarding choices
for sedation that do not require an intravenous (IV) or intramuscular (IM) injection. The leading
choice has been midazolam, as various routes can be used without the need for any injection.
Midazolam, a water-soluble benzodiazepine, improves children's anxiety due to its fast onset,
anterograde amnesia anxiolysis, and sedation effects. The problem posed with this choice is the
added risk of respiratory depression as associated with all benzodiazepines.
Scope of the Problem
Anxiety is a large predictor of undesirable outcomes postoperatively.5 The frequency of
negative behavioral changes includes aggression, nightmares, and separation anxiety. 5 Also, this
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anxiety influences the demand for increased pain control.6 The lack of control of anxiety now is
known to contribute to the alteration of pain neuropathways for children.6
Research has shown a correlation of delirium from observing 580 admissions in a
pediatric intensive care unit (PICU).7 The 580 patients over 6 months demonstrated a 43%
increase of delirium when administered a benzodiazepine.7 The routine administration of
benzodiazepine proves it could affect a large portion of the population of pediatric patients.
Therefore, a further review of these potential adverse side effects should be examined and
studied.
Consequences of the Problem
The issue of leaving the routine administration of benzodiazepines as the status quo could
alter learning and cognitive behavior.8 Brain cell death has been shown in animal models when
exposed to γ-aminobutyric acid receptor agonists.8 The developing brain of children is at risk
when exposed to these associated drugs. There should be a desire to find less harmful alternatives
for the sake of the patients and their families.
The results of 71,996 children study suggest a moderate association between γaminobutyric acid receptor agonists exposure and children demonstrating internalizing problems
that are not likely due to stable familial confounding factors.9 Delirium is a prime example that
the neurochemistry is potentially being altered. Dexmedetomidine diminishes that effect and
carries other benefits when compared to benzodiazepines such as midazolam.
Background
Dexmedetomidine is a drug that has been around since December 1999 and has only
grown in acceptance.3 Dexmedetomidine is a specific alpha 2 adrenoreceptor agonist and a highly
selective and potent drug containing both analgesia and sedative effects. 4 Current practices in
intensive care and emergency departments have seen the advantages of using dexmedetomidine
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as a first-line agent instead of midazolam because it can produce analgesia, cause less respiratory
depression, and result in less delirium.4 Because children are the main focus of this study, these
additional benefits are an advantage. Even while under the influence of dexmedetomidine,
patients can still interact more clearly as the drug provides a different sedation type of effect
compared to benzodiazepines.4
PICO
P - Pediatrics I - Dexmedetomidine C - Midazolam O - Reduction of adverse/side effects for
sedation
Does dexmedetomidine or midazolam work better to reduce the adverse/side effects of sedation for
pediatric patients?
Knowledge Gaps
A large gap of information is missing in respects to the altering effects of
benzodiazepines and how it affects the neurochemistry of the child. Clinicians are at a
disadvantage with the lack of information that can alter the decision making process. Multiple
studies and trials will be required to narrow the amount of low-quality evidence that presently
exists.8 It is necessary to determine how the dose, duration, and frequency of drugs such as
dexmedetomidine and midazolam interfere with cognitive and behavioral functions. 8
Proposal Solution
The use of dexmedetomidine in contrast to midazolam for sedation has comparable
effects that are satisfactory for sedation in a wide array of procedures. The proposed study to
substitute the two medications will not only allow safer administration and control of the sedation
but eliminate the unwanted side effects. These side effects, such as delirium, respiratory
depression, laryngospasms, and possible neurotoxicity, can therefore be carefully reviewed and
create a new standard of care.
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SUMMARY OF LITERATURE
Summary of Evidence
The literature review included 10 RCTs that allowed for a wide variety of patients from
different parts of the world. The large sample sizes and consistent findings from the research can
lead to a definitive conclusion. The exclusion criteria consisted of eliminating any research that
went outside the boundary for the ages of 2-14, children who did not receive any pre-medication,
and children that received a combination of sedatives. Studies were also excluded that
encompassed results outside of peri-operative sedation, postoperative pain control, and
emergence delirium.
The quality of evidence for the RCTs was appraised by using the Johns Hopkins research
evidence appraisal tool11, which allowed for consistent standards in judging the results. All 10 of
the studies had a level 1 rating, which indicates the use of randomized controlled trials. The
associated letter and subclassification determined how well the research parameters and study
results are graded. The selection of this literature review included five Level 1A studies, four
Level 1B, and one Level 1C study.
From the 10 RCTs, all the research concluded that dexmedetomidine adequately sedated
the children pre-operatively, which allowed for a decrease in separation
anxiety.12,13,14,15,16,17,18,19,20,21 Only one RCT acknowledged that the difference between
medications was negligible and recommended the use of midazolam for its lower price point. 20
Two of the RCTs pointed out the prolonged onset of action of dexmedetomidine as a negative to
take into account when comparing the two medications.13,21
Information Sources and Search Strategy
To meet the standards of systematic reviews, PRISMA (Preferred Reporting Items for
Systematic reviews and Meta-Analyses) was used as a guideline.10 The 27-item checklist helps to
report and evaluate current research.10 In doing so, it allows for critical appraisal of interventions
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and randomized control trials that have been conducted.10 The PRISMA tool is invaluable as
clinicians further develop and analyze current research.
The databases used to identify the most accurate and relevant research included the use of
the Cochrane Database of Systematic Reviews, Cumulative Index of Nursing and Allied Health
Literature (CINAHL), Google Scholar, Medline (ProQuest), and PubMed electronic database.
The keywords used in the search were dexmedetomidine, midazolam, premedication, (kids or
youth or pediatric or children or toddler). The PRISMA flow diagram in Figure 1 helps illustrate
the screening process.
Table 1: Database Search Table
Database

PubMed

Boolean
Phrase

“Dexmedetomidine”
AND “Midazolam”
AND
“Premedication”
AND “Kids” OR
“youth” OR
“pediatric” OR
“children” OR
“toddler”

Search
Results

58

CINAHL
-

16

Medline
(ProQuest)
-

296

Cochrane

Google

-

-

89

42

Study Selection and Screening Method with Inclusion/Exclusion Criteria
The study selection was conducted using five databases and Endnote to help filter
through duplicates. The Cochrane search yielded 89 results, CINAHL 16 results, PubMed 58
results, Medline 296 results, and Google Scholar 42 results for a total of 501 records. Once the
results were input to Endnote, 315 duplicates were identified and removed. The remaining 186
records were then screened for randomized controlled trials (RCT). Once the full-text results were
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narrowed down to 39, the leftover records were eliminated due to the lack of similarity to the
PICO question, leaving 10 studies to critique.
The inclusion criteria consisted of pediatric children under the age of 14 who were
observed in the preoperative setting. These children also had to be given dexmedetomidine or
midazolam to compare with each other. The route of administration preference is intranasally to
demonstrate how to avoid issues with intravenous catheter insertions. The chosen articles are
Random Controlled Trialed (RCT) based; these methods of studies help prevent bias and allow to
show a higher quality of evidence. The outcomes in these studies focused on sedation effects,
pain control, and emergence delirium post-procedure.
The exclusion criteria consisted of children older than 14 years old and those not given
dexmedetomidine or midazolam as premedication before a procedure. If the children were given
more than one of the aforementioned drugs, this would also exclude the study as the purpose is to
measure the two drugs in direct comparison. Any studies that were not RCT were not considered
or any research older than from 2010. The outcomes other than pain control, sedation effect, and
emergence delirium were not considered.
Table 2. Inclusion and Exclusion Criteria
Inclusion
Population:
 Peri-operative setting; “Premedication”
 Pediatric children 2-14 years old
Intervention
 The use of midazolam or dexmedetomidine in
the same study preoperatively
 Intranasal route of administration
Outcomes:
 Effectiveness of sedation preoperatively
 Reduced pain postoperatively
 Reduced emergence delirium
Type of study:
 Research studies conducted from 2010 to 2020
 RCTs

Exclusion
Population:
 Children younger than 2
years and older than 14
years
 Patients who didn’t receive
“premedication”
Intervention:
 Any patients receiving
midazolam or
dexmedetomidine in
combination with other
sedatives
Outcomes:
 Anything other than perioperative sedation,
postoperative pain control,
and emergence delirium
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Category of research:
 Articles prior to 2010
Collection, Analysis, and Data Items
The gathering of research was done methodically in accordance with the Johns Hopkins
research evidence appraisal tool.11 The tool is categorized into five evidence levels, where each
classification helps distinguish the articles by the format the authors conducted the research. The
Level I classification includes experimental studies, randomized controlled trials (RCT),
explanatory mixed-method design, and systemic review of RCTs, with or without metaanalysis.11 The Level II classification includes quasi-experimental studies, explanatory mixedmethod design with a level II quantitative study, a systemic review of a combination of RCTs and
quasi-experimental studies, or quasi-experimental studies only, with or without meta-analysis. 11
The levels III and above are considered to be the least reliable of evidence and thus were not used
for this review.
In regards to the quality ratings for quantitative studies, there are three alphabetical
ordered classifications. The “A” rating signifies a high-quality study that demonstrates consistent,
generalizable results, sufficient sample size for the study design, adequate control, definitive
conclusions, and consistent recommendations based on fairly comprehensive literature through
scientific evidence.11 The “B” rating is defined as having reasonably consistent results, sufficient
sample size for the study, some control, fairly definitive conclusions, and reasonably consistent
recommendations based on a fairly comprehensive literature review that includes some reference
to scientific evidence.11 The “C” rating is used when the study demonstrates low quality or
significant research design flaws. With inconsistent results, these studies are defined by little
evidence, an insufficient sample size for the design, and conclusions that could not be drawn. 11
The articles that were selected only met the highest of marks as RCTs. The
comprehensive search included studies that were most relevant to the PICO question posed. “In
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the pediatric population, does dexmedetomidine or midazolam serve as the best medication to
reduce adverse and side effects for sedation?” Adhering to these strict guidelines for inclusion
and exclusion allowed narrowing the focus of this analysis. It led to 10 studies that favorably
mirrored the answer to the PICO question.
Study Characteristics
The 10 studies conducted had a total of 828 participants. From these totals, 397 of the
patients were given dexmedetomidine intranasally, 32 patients were administered ketamine, and
399 were given midazolam. The age demographic spread from age 2-14 years old. The research
conducted spanned from 2011-2020 while all following a randomized control trial (RCT) format.
According to the Johns Hopkins research evidence appraisal tool, the benefit of the RCTs helped
establish a minimum of quality to the research, as they were all at a minimum of level 1C. 11 The
children in the studies were also from different backgrounds, including countries such as China,
India, South Africa, Saudi Arabia, Egypt, and Spain.
Risk of Bias
For this literature review, the Cochrane Handbook Collaboration Tool was used for
assessing bias.22 The 10 research studies were completed as randomized controlled trials (RCTs),
thus demonstrating a minimum of a double-blind process through their methods. One of the RCTs
by Surendar et al.19 was completed using a triple-blind method. All of the ten RCTs showed a low
risk of bias for random sequence and selective reporting. However, the RCT done by Ghosh et al.
had unclear allocation concealment and, therefore, offers a possibility of bias.22
THEORETICAL FRAMEWORK
The theoretical framework to be implemented targets the subject group of learners who
are certified nurse anesthetists (CRNA). Malcolm Knowles in 1980 developed the popular
concept of andragogy and what is now known as the adult learning theory (ALT).23 The adult
learning theory focuses on organizing new ways to help adults learn and retain information. As

14
people age, the neuroplasticity in the brain declines, where new needs are created for learning.24
To overcome this barrier, Knowles stipulated that adults need to know why they are required to
learn something new and how learning this new information will benefit them specifically. 24 The
other main factor is adults also have a tendency to draw from past experiences and knowledge to
help form the way they process information.24
In following the ALT

and using its foundational assumptions on how adults learn, a

questionnaire was developed to provoke interest and the internal drive for the participants to
learn. A PowerPoint presentation was created to drive the main points of the teaching and
encourage change in everyday practice. The participants selected are all graduate-level or clinical
doctorate-employed CRNAs. The educational instruction is provided at no cost and is readily
available at the convenience of the participant. In the effort to establish the method for this
educational intervention, the adult learning theory incorporated the best background to achieve
this goal.
METHODOLOGY
Setting
The setting was a full-service children's hospital with seven operating rooms and two
procedural rooms located in South Florida. The children’s hospital treats all types of diseases
and injuries ranging from minor to complex medical conditions.
Recruitment
The recruitment targeted CRNA alumni from Florida International University that
specialized in pediatrics. The participants were identified using the alumni list through the
university. The CRNAs were emailed a request to participate in the project.
Participants
The only participants invited to partake in the project were pediatric CRNAs who work in
the operating room setting to see through the whole peri-operative process. All other CRNAs that
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did not specifically treat pediatric children or worked in a setting other than the operating room
were excluded from participation. The entire list of CRNAs that met the inclusion criteria was
emailed a pretest and posttest.
Intervention
The intervention was to provide an educational module-based presentation, and a
Qualtrics survey was used to help administer pre-and posttesting. The baseline knowledge of the
practitioners participating in the lecture was assessed, as well as the likelihood of willing to
change practices in respect to sedation for pediatric patients. The presentation should establish a
significant enough reason to venture into new protocols for the pediatric population.
The proposed change in practice is first to prepare the patient to have intranasal
dexmedetomidine administered 45 minutes prior to induction. According to previous studies,
doses of 1-1.5 mcg/kg can be used for optimal sedation scores. Once the patient is calm, placing
ECG leads, SPO2, and BP cuff to monitor vitals would occur. The preoperative nurse can also
keep an atropine syringe in case of an emergency for bradycardia.
Procedures
The procedure to deploy the educational module began with an informational email
requesting for participation. All participants pre-selected from the alumni database at Florida
International University had no identifiable information attached to the surveys. The results of the
examinations were done anonymously and protected through Qualtrics. A 2-week grace period
was given to complete the questions and submitted for the results.
Protection of Human Subjects
The participants included in the surveys were protected by anonymous submission of
results. The Qualtrics system allowed for anonymous links and responses for the pretest and
posttest. This anonymity protected survey participants.
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RESULTS
The educational module had 5 CRNA participants (n = 5) who completed 100% of the
pretest and posttest. This allowed for no changes in the demographics and had no attrition for
those who took part in the education. The participants race consisted of four Hispanics (n = 4;
80%) and one Caucasian (n = 1; 20%). The sex of the participants were three males (n = 3; 60%)
and two females (n = 2; 40%). The majority included CRNAs in the 30-39 age range (n = 3; 60%)
and the remaining in the 40-49 age range (n = 2; 40%).
Table 3: Demographic Characteristics
Demographics
Total Participants

n (%)
5 (100%)

Age
<30 years

0

30-39

3 (60%)

40-49

2 (40%)

>60

0
Gender

Male

3 (60%)

Female

2 (40%)
Ethnicity

Hispanic

4 (80%)

Caucasian

1 (20%)

Pretest Knowledge
From the 5 CRNAs’ pretest answers, there was a demonstration that an opportunity
existed to increase their knowledge base through the module. The first question in regards to
factors that influenced children’s anxiety pre-operatively were all answered incorrectly (0%). The

17
next three questions asked what receptors midazolam and dexmedetomidine worked on as well as
which drugs could be used for sedation and pain. All five CRNAs answered those three questions
correctly (100%). The majority of the CRNAs also had some difficulty in answering question
items regarding to the side effects of midazolam and dexmedetomidine. The main problem was
the lack of knowledge that midazolam, although rare, has a possibility of causing a laryngospasm,
only one CRNA answered it correctly (20%). The next question in the survey was about which
main factor was a predictor for post-operative outcomes, and all the CRNAs answered this
correctly (100%). The following question, answered correctly by 40% of the CRNAs, asked what
medication was responsible for adverse effects of altered learning and cognitive behavior. Finally,
the last question was only correctly answered by one CRNA (20%) in regards to what effects are
seen post-operatively due to anxiety before the procedure.
Posttest Knowledge
The five CRNAs that participated all completed the posttest after viewing the PowerPoint
presentation. This video was played immediately after the pretest. The goal was to see if any new
knowledge could be learned for the post evaluation after the video. On the topic of stress factors
that play a role in children pre-operatively, there was 60% increase (n = 3) in participants who
answered this correctly. The question on the side effects of midazolam saw an improvement as n
= 3; 60% answered correctly in comparison to n = 1; 20%. For dexmedetomidine side effects (n =
4; 80%) of the participants correctly answered the question. The following item discussed adverse
effects on cognitive leaning and behavior of children. There was an increase in correct responses
that resulted in n = 4; 80%. Finally, the last question on the survey asked about the effects of preoperative anxiety seen after the procedure. A total of n = 3; 60% of CRNAs answered correctly.
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Table 4. Difference in Pretest and Posttest Knowledge
Correct Responses
1. WHAT FACTORS PLAY A ROLE IN
STRESS FOR CHILDREN BEFORE
SURGERY? SELECT ALL THAT APPLY
A)

Pretest

Posttest

Difference

0%

60%

+60%

100%

100%

-

100%

100%

-

100%

100%

-

20%

60%

+40%

40%

80%

+40%

PARENTS ANXIETY LEVEL

C)
CHILD’S PREVIOUS
EXPERIENCE
D)

ANESTHETIC USED

2. WHAT MEDICATIONS CAN BE USED
FOR BOTH SEDATION AND
ANALGESIA?
B)

DEXMEDETOMIDINE

3. WHAT RECEPTORS DOES
DEXMEDETOMIDINE WORK ON?
D)

ALPHA 2

4. WHAT RECEPTORS DOES
MIDAZOLAM WORK ON?
A)

GABA A

5. IDENTIFY A POTENTIAL ADVERSE
EFFECTS FROM MIDAZOLAM IN
CHILDREN? SELECT ALL THAT APPLY
A)

LARYNGOSPASM

C)

RESPIRATORY DEPRESSION

6. WHAT ARE SOME POTENTIAL
ADVERSE EFFECTS FROM
DEXMEDETOMIDINE? SELECT ALL
THAT APPLY
A)

BRADYCARDIA

B)

HYPOTENSION

C)

HYPERTENSION

D)

DRY MOUTH
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7. WHAT IS A SIGNIFICANT
PREDICTOR OF UNDESIRABLE
OUTCOMES POST-OPERATIVELY?
C)

100%

100%

-

40%

80%

+40%

20%

60%

+40%

ANXIETY

8. WHICH MEDICATION CAN HAVE
ADVERSE EFFECTS OF ALTERED
LEARNING AND COGNITIVE
BEHAVIOR?
D)

MIDAZOLAM

9. WHAT ARE SOME EFFECTS OF
PRE-OPERATIVE ANXIETY SEEN
POSTOPERATIVELY? SELECT ALL
THAT APPLY
A)
INCREASED REQUIRED
AMOUNTS OF PAIN
MEDICATION
B)

EMERGENCE AGITATION

Figure 1.

PRE- & POSTTEST SCORES
Pre-test

Post-test

Difference

120

Percentage

100
80
60
40
20
0
Q1

Q2

Q3

Q4

Q5

Q6

Number of Correct Answers

Q7

Q8

Q9
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DISCUSSION
Anxiety in children has been linked as a significant influence on postoperative
complications. These complications include increased postoperative pain, hemodynamic
fluctuations, metabolic disarrangement, and emergence agitation.1 The goal for all team members
who are involved for taking care of children through the surgical experience is to produce the best
safe outcomes for the patients. The focus of these outcomes presents an opportunity to
acknowledge the potential negative effects of maintaining traditional methods of preoperative
sedation. The family of benzodiazepines has demonstrated these unwanted side effects not only
affect short-term but potentially long-term health as well with neurological changes to learning
and cognitive behavior.8
The solution is to try to employ the use of dexmedetomidine when possible, instead of the
commonly used midazolam. The benefits of better sedation and relief of anxiety results in
avoiding the large number of negative outcomes benzodiazepines can produce. The barriers to
employ this method vary from institution in respects to timing and costs of the medications. As a
result, discussions should take place amongst hospital leadership on how to make these changes
conceivable. The research available demonstrates dexmedetomidine as the better medication for
most patients preoperatively. The knowledge gap on long-term effects of benzodiazepines for
children is of concern and should be a driving force to implement change.
Finally, there are circumstances where drugs such as midazolam are needed. Children
with autism, behavioral problems, and teenagers can present challenges where the faster onset of
the medication outweighs the potential risks of midazolam. Each medication has its pro and cons
but hopefully will be used when appropriately called for.
IMPLICATIONS
The future of anesthesia is always evolving as more research and new drugs enter the
market. The long-term impact of our current medications on children still has not been well
established. In continuing with the status quo, we are unnecessarily exposing children to
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medications that can be avoided. As of 2020, dexmedetomidine not only causes better sedation
but reduces the risks of altering learning and cognitive behavior. 5 GABA agonists have been
linked to brain cell death in animal models, yet no human studies have been conducted. 5,25
This sample of current CRNAs demonstrates an opportunity for quality improvement in
daily practice. Current practitioners should have the choice in how they practice to advocate for
the patient. If more practicing CRNAs can be made aware of the benefits and reduction of
detrimental risks, then practitioners can get to be one step closer to achieving safer anesthesia.
Better sedation that is established can help throughout the whole perioperative experience for the
children.
CONCLUSION
The studies' results have been consistent and clear that dexmedetomidine has been
comparable if not better than midazolam for preoperative sedation and postoperative analgesia.
The use of dexmedetomidine can help curb unwanted side effects that can greatly affect children
such as respiratory depression and possible laryngospasms with midazolam. The movement to
change this common practice of midazolam administration should be done when advantageous
for the patient. This is the sole focus of improving patient experiences and outcomes.
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APPENDIX A: PRISMA Flow Diagram

Identification

Figure 1:

Records identified through
database searching
(n = 501)

Additional records identified
through other sources
(n = 0)

Screening

Records after duplicates removed
(n =315)

Records screened
(n = 186)

Included

Eligibility

Full-text articles assessed
for eligibility
(n = 39)

Studies included in
qualitative synthesis
(n = 10)

Records excluded
(n = 147)

Full-text articles
excluded, with reasons
(n = 29)
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APPENDIX B: MATRIX TABLE

Table 5. Studies Included in Appraisal
Title

Design/ Method

Sample/ Setting

Major
Variables
Studied and
Their
Definitions

Measurement
& Data
Analysis

Findings

Results & Conclusions

Appraisal Worth to
Practice Level

Design: RCT

90 patients Age
(6-11)

Group D =
dexmede
tomidine

Numerical
rating scale
(NRS)=Patient
satisfaction
Modified Yale
Preoperative
Anxiety Scale
=(m‐YPAS)21

Dexmede
tomidine effectively
lowered separation
anxiety along with pain
and agitation
postoperatively

Level 1A

Group M =
midazolam

Scores of 23.5‐30
indicate no or
mild anxiety,
whereas scores
>30 indicate
severe anxiety

Authors
(Year)
Citation
The comparison of
dexmedetomidine and
midazolam
premedication on
postoperative anxiety in
children for hernia
repair surgery
Du Z, Zhang Y, Qu S,
Song Z, Wei SW, Xiang
Z, Guo QL
(2019)
Citation #12

Method: To
determine the
effects of
premedication
on
postoperative
anxiety

n = 45 received
an intravenous
infusion of
dexmedetomidine
n = 45
received an
intravenous
infusion of
midazolam
Setting: Hunan
Children’s
Hospital
Hunan, China

(Group M
Baseline=27.88 ±
3.34 ;5 min post
admin
29.29 ± 4.34)
(Group D Base
line=
28.15 ± 6.38; 5
min post admin=
32.71 ± 9.99)
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Intranasal
dexmedetomidine versus
intranasal midazolam as
pre-anesthetic
medication in pediatric
age group undergoing
adenotonsillectomy
Bassem BS, Tharwat A,
Ghobrial H, Elfawal S

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

(2020)
Citation # 13

48 patients
ASA 1
Age (3-7)
(n = 24)
intranasal
dexmedetomidine
(n = 24)
received
intranasal
midazolam

Group D
received
intranasal
dexmedetomidine

Modified
Observers
Assessment of
Alertness/Seda
tion Scale
=(MOAA/S)

Group M
received
intranasal
midazolam

Anxiety Scale

Group A=
Midazolam

Numerical
rating scale for
sedation,
behavior

Sedation score in
dexmedetomidine
group is 2.53 ±
0.74; in
midazolam group
is 3.69 ± 0.87

The midazolam group at
the 10 min and 20 min
had better sedation
compared to the
dexmede-tomidine group.
The intranasal dexmedetomidine was more
effective at the 30- and
45- min mark.

Level 1A

Sedation scores at
induction.
Group AScores <4= 23.3%
;
Scores >5= 76.7%

Initially, Group A
(midazolam) had better
sedation scores.

Level 1B

Child
Separation
Scale

University
Hospitals
Cairo, Egypt
Efficacy of intranasal
dexmedetomidine versus
oral midazolam for
paediatric premedication
Lakshmi K, Kumar A,
Panikkaveetil R, Vasu B,
Rajan S, Nair S
(2017)
Citation # 14

Design: RCT
Method: To
determine the
effects of
premedication
for sedation and
separation
anxiety

60 Patients
ASA 1-2
Age (2-12)
(n = 30)
Intranasal
dexmedetomidine
(n = 30)
Intranasal
Midazolam

Group B=
dexmedetomidine

Group BScores <4=83.3%;
Scores >5= 16.7%

In the end, intranasal
dexmedetomidine at a dose of 1
μg/kg had better sedation
scores when compared to
midazolam orally.
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Amrita
University
Karala, India
Preanesthetic medication
in children: A
comparison of intranasal
dexmedetomidine versus
oral midazolam
Ashraf M, Abdul Kader
M, Maher A
(2011)
Citation #15

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

120 patients
Age (4-12)
(n = 60)
Intranasal
dexmedetomidine
(n = 60)
Oral
Midazolam

Group D
received
intranasal
dexmedetomidine
Group M
received oral
midazolam

Yale
preoperative
anxiety scale
(YPAS)
Sedation level
was analyzed
with a six
point sedation
scale; It was
changed from
the original
(MOAA/S)

Sedation score
baseline in
dexmedetomidine
group is 5.86 ±
0.14; in
midazolam group
is 5.92 ± 0.08
Transfer to OR for
Group D =
2.94 ±1.37
Group M = 3.99
±1.58

Children premedicated
with intranasal dexmedetomidine had better
sedation and lower
anxiety when compared to
oral midazolam

Level 1B
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A Comparative
Evaluation of Intranasal
Dexmede-tomidine &
Intranasal Midazolam
for Preoperative
Sedation in Children
Ghosh A, Das A,
Mukherjee M, Begum, S

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

(2020)

90 Patients
ASA 1 & 2
Age (2-8)

Group A =
dexmedetomidine

(n = 42)
Intranasal
dexmedetomidine

Group B =
midazolam

Ramsay
Sedation Scale
& Observer
Pain Scale

Satisfactory
sedation for group
A at
induction=93%;

Intranasal Dexmedetomidine has a better
sedative and analgesic
effect when compared to
midazolam

Level 1A

Premedication with
intranasal dexmedetomidine decreased
anxiety, and allowed for
improved parent
separation and mask
acceptance versus
intranasal midazolam

Level 1A

Satisfactory
sedation at
induction for
Group B= 60%

(n = 48)
Intranasal
Midazolam

Citation #16
RG Kar
Medical
College
Kolkata,
India

Comparison of
dexmedetomidine versus
midazolam for intranasal
premedication in
children posted for
elective surgery
Singla D, Chaudhary G,
Dureja J, Mangla M
(2015)

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

Patients 60
ASA 1
Age (3-10)

Group D=
dexmedetomidine

(n = 30)
Intranasal
dexmedetomidine

Group M=
midazolam

(n=30)
Intranasal

Modified
Observers
Assessment of
Alertness/Seda
tion Scale
(MOAA/S)
Four-point
Parental
Separation

Sedation for
Group M at 20
min post
administration=
3.53±1.14
Group D at 20
min= 2.93 ± 1.143
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Midazolam

Anxiety Scale
(PSAS)

Citation # 17
Bhagat Phool
Singh Govt
Medical
College and
Hospital for
Women
Haryana, India

Pre-anesthetic
medication with
intranasal
dexmedetomidine and
oral midazolam as
anxiolytic. A clinical
trial
Linares Segovia B,
García Cuevas I,
Ramírez Casillas J,
Guerrero Romero I,
Botello Buenrostro R,
Monroy Torres X,
Ramírez Gómez
(2014)
Citation #18

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

108 Patients
Age (2-12)
(n = 52)
Intranasal
dexmedetomidine
(n = 56)
Oral
Midazolam

Group A=
pre-anesthetic
medication
with oral
midazolam
and intranasal
placebo
Group
B=intranasal
dexmedetomidine and
placebo
orally

Modified Yale
scale for
anxiety

Anxiety in
dexmedetomidine
group at
60 minutes had Pvalues (p = .001);
at induction (p
=.04); at recover
(p = .0001)

Children premedicated
intranasal dexmedetomidine had better
sedation and lower
anxiety when compared to
oral midazolam

Level 1B

32

A comparative
evaluation of Intranasal
Dexmedetomidine,
Midazolam and
Ketamine for their
sedative and analgesic
properties: A Triple
Blind Randomized Study
Surendar MN, Pandey
RK, Saksena AK, Kumar
R, Chandra G
(2014)
Citation #19

Design: RCT
Method:
Comparing
Intranasal (IN)
Dexmedetomidi
ne, Midazolam
and Ketamine
in producing
moderate
sedation

84 Patients
ASA 1
Age (4-14)

(n = 21)
Intranasal
dexmedetomidine dose
1μg/kg
(n = 21)
Intranasal
dexmedetomidine dose
1.5μg/kg

Group D1=
dexmedetomidine dose
1μg/kg

(n=21)
Intranasal
Ketamine

Sedation
satisfaction –
Dexmedetomidine
at dose 1μg/kg=
19 (90.5%)

Group D2=
dexmedetomidine
dose 1.5μg/kg

dexmedetomidine
dose 1.5μg/kg
= 20 (95.2%)

Group M=
midazolam

Intranasal
Midazolam=
15(71.4%)

Group K=
Ketamine
(n=21)
Intranasal
Midazolam

Measured
through
behavior and
vital signs

Intranasal
Ketamine= 16
(76.2%)

Determined all 3 drugs
were suitable for sedation
pre-operatively with
dexmede
tomidine having the most
success

Level 1C
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Premedication with
intranasal
dexmedetomidine,
midazolam and ketamine
for children undergoing
bone marrow biopsy and
aspirate
Mostafa MG, Morsy KM
(2012)

Design: RCT
Method:
Comparing
Intranasal (IN)
Dexmedetomidi
ne, Midazolam
and Ketamine
in producing
moderate
sedation

Citation #20

96 patients
ASA 2
Age (2-8)
(n = 32)
Intranasal
dexmedetomidine

Group D=
dexmedetomidine

Group M=
midazolam

4-point
sedation scale
4-point childparent
separation
scale

Sedation score at
20 min;
Midazolam =
2.21 ± 0.70
Ketamine=
2.41 ± 0.68

All three drugs
demonstrated adequate
sedation but the authors
recommend midazolam
for the lower price point

Level 1 A

Intranasal dexmedetomidine is a superior
drug for sedation but has
prolonged time onset of
action

Level 1B

Dexmedetomidine
= 2.10 ± 0.71

Group K=
Ketamine
(n = 32)
Intranasal
Midazolam
(n = 32)
Intranasal
Ketamine

Intranasal
dexmedetomidine vs
midazolam for
premedication in
children undergoing
complete dental
rehabilitation
Sheta SA, Al-Sarheed
MA, Abdelhalim AA

Design: RCT
Method: To
compare effects
of
premedication
to reduce
anxiety and
sedation level
prior to surgery

72 patients
ASA 1&2
Age (3-6)

Group D=
dexmedetomi
dine

(n=36)
Intranasal
dexmedetomidine

Group M=
midazolam

*Awaiting full
article

Sedation scores
Group D =77.8%;
Group M= 44.4%
At (P = 0.002).
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(2014)
Citation # 21

(n = 36)
Intranasal
Midazolam

35

Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To: Dr. Yasmine Campbell
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From: Maria Melendez-Vargas, MIBA, IRB Coordinator
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2021
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module”
The Florida International University Office of Research Integrity has reviewed your
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As a requirement of IRB Exemption you are required to:
1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the procedures
involving human subjects. All additions and changes must be reviewed and approved prior to
implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or unanticipated
adverse event, problems with the rights or welfare of the human subjects, and/or deviations from
the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished
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Special Conditions: N/A
For further information, you may visit the IRB website at http://research.fiu.edu/irb. MMV/em

36

Welcome to the QI project!
Pretest and Posttest Questionnaire:
The use of Dexmedetomidine to mitigate perioperative anxiety in pediatric patients
receiving general anesthesia: An evidence-based education module
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of dexmedetomidine for
perioperative anxiety in pediatric patients receiving general anesthesia.
You will be presented with information on medications to treat perioperative anxiety and asked
to answer some questions about it. Please be assured that your responses will be kept completely
confidential.
The study should take you around five minutes to complete, and you will receive no incentive for
your participation. Your participation in this research is voluntary. You have the right to
withdraw at any point during the study, for any reason, and without any prejudice. If you would
like to contact the Principal Investigator in the study to discuss this research, please e-mail Felipe
Ocampo Pocam001@fiu.edu
By clicking the button below, you acknowledge that your participation in the study is voluntary,
you are 18 years of age, and that you are aware that you may choose to terminate your
participation in the study at any time and for any reason.
Please note that this survey will be best displayed on a laptop or desktop computer. Some
features may be less compatible for use on a mobile device.

37
Questionnaire
1. What factors play a role in stress for children before surgery? Select all that apply
A) Parents anxiety level
B) Location of operative site
C) Child’s previous experience
D) Anesthetic used
E) Length of hospitalization
2. What medications can be used for both sedation and analgesia?
A) Midazolam
B) Dexmedetomidine
C) Propofol
D) Tylenol
3. What receptors does dexmedetomidine work on?
A) GABA A
B) GABA B
C) Alpha 1
D) Alpha 2

4. What receptors does midazolam work on?
A) GABA A
B) GABA B
C) Alpha 1
D) Alpha 2
5. Identify a potential adverse effects from midazolam in children? Select all that apply
A) Laryngospasm
B) Bradycardia
C) Respiratory depression
D) Nausea
6. What are some potential adverse effects from dexmedetomidine? Select all that apply
A)
B)
C)
D)

Bradycardia
Hypotension
Hypertension
Dry mouth

7. What is a significant predictor of undesirable outcomes post-operatively?
A) Sex of the patient
B) Height
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C) Anxiety
8. Which medication can have adverse effects of altered learning and cognitive behavior?
A)
B)
C)
D)

Ketamine
Fentanyl
Dexmedetomidine
Midazolam

9. What are some effects of pre-operative anxiety seen postoperatively? Select all that apply
A) Increased required amounts of pain medication
B) Emergence agitation
C) Decreased hunger
D) Nausea
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